Emerging Company Profile Eurona: Genetic profiling for the clinic

The influence of individual genetic factors on responses to treatment can greatly complicate the task of developing drugs for the general population. Eurona Medical is creating a niche out of that problem, using individual genetic analysis to help design clinical programs and effective therapeutics targeted at subgroups of patients likely to respond to a given drug.

Eurona offers clinical services to companies at every phase of development. For clinical programs, partners subscribe to Eurona's database, which relates genetic information to treatment outcome.